We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search

Clear all

Refine your search

13 results found

Article

Carpmaels & Ransford LLP | United Kingdom, European Union | 7 Dec 2017

SPCs: clarity on claims with functional features?

The German Federal Patent Court has asked the CJEU how its “implicitly, but necessarily and specifically” test for assessing Article 3(a) of

Article

Carpmaels & Ransford LLP | European Union, Germany | 22 Nov 2017

New referral regarding SPC availability for certain medical devices

A new question has been referred to the European Court of Justice by the German Federal Patent Court on the availability of supplementary protection

Article

Carpmaels & Ransford LLP | United Kingdom, European Union, Germany | 3 Aug 2016

No jurisdiction over foreign designations of European patents where validity is also challenged

The High Court recently dismissed a request to hear an infringement action in respect of the German designation of a European patent. In reaching

Article

Carpmaels & Ransford LLP | United Kingdom, European Union | 22 Apr 2015

SPCs for biologics guidance on product definitions, scope and validity from EFTA court

The EU Supplementary Protection Certificate (SPC) Regulation (4692006) has been the subject of extensive analysis and numerous referrals to the

Article

Carpmaels & Ransford LLP | United Kingdom, European Union | 30 Jul 2014

Patentable parthenotes? Advocate general says yes

Good news could be on the horizon for stem cell patenting in Europe, following the advocate general's opinion in the most recent stem cell case to be

Article

Carpmaels & Ransford LLP | United Kingdom | 6 Nov 2013

Extending pharmaceutical patents in the United Kingdom

The contentious issue of patent extensions for pharmaceutical products has again come under the spotlight in a recent decision: Actavis v Boehringer

Article

Carpmaels & Ransford LLP | European Union | 21 Aug 2013

hES cell patents in Europe what’s the point?

"hES cell patents in Europe - the inescapable Brustle trap?" discussed the controversy regarding human embryonic stem cell (hES cell) patents in

Article

Carpmaels & Ransford LLP | United Kingdom, European Union | 14 Nov 2012

SPCs remain in a state of flux

The UK High Court recently asked the European Court of Justice to clarify what is meant by the “first authorisation” for the purposes of calculating the duration of an supplementary protection certificate (SPC).

Article

Carpmaels & Ransford LLP | United Kingdom, European Union | 3 Oct 2012

UK court looks for more help from ECJ

In a judgment that echoed with resentment over the opacity of several recent Court of Justice of the European Union decisions in the area of supplementary protection certificate law, the Hon Mr Justice Arnold of the UK High Court has decided to refer two questions back to the ECJ, saying in effect “try again"!

Article

Carpmaels & Ransford LLP | European Union | 20 Jun 2012

Furrowed brows for L’Oréal at end of allergan BOTOX battle

The First Chamber of the Court of Justice of the European Union has given its judgment dismissing the appeal brought jointly by Helena Rubenstein and L’Oréal against the 2010 judgment of the EU General Court in favour of Allergan, Inc, owner of the BOTOX trademark.

Previous page 1 2